Skip to main content
Top
Published in: Current Pulmonology Reports 4/2012

Open Access 01-12-2012 | Asthma (S Peters and J Oppenheimer, Section Editors)

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort

Authors: Bradley E. Chipps, Robert S. Zeiger, Alejandro Dorenbaum, Larry Borish, Sally E. Wenzel, Dave P. Miller, Mary Lou Hayden, Eugene R. Bleecker, F. Estelle R. Simons, Stanley J. Szefler, Scott T. Weiss, Tmirah Haselkorn, TENOR Study Group

Published in: Current Pulmonology Reports | Issue 4/2012

Login to get access

Abstract

Patients with severe or difficult-to-treat asthma account for substantial asthma morbidity, mortality, and healthcare burden despite comprising only a small proportion of the total asthma population. TENOR, a multicenter, observational, prospective cohort study was initiated in 2001. It enrolled 4,756 adults, adolescents and children with severe or difficult-to-treat asthma who were followed semi-annually and annually for three years, enabling insight to be gained into this understudied population. A broad range of demographic, clinical, and patient self-reported assessments were completed during the follow-up period. Here, we present key findings from the TENOR registry in relation to asthma control and exacerbations, including the identification of specific subgroups found to be at particularly high-risk. Identification of the factors and subgroups associated with poor asthma control and increased risk of exacerbations can help physicians design individual asthma management, and improve asthma-related health outcomes for these patients.
Literature
1.
go back to reference World Health Organization (WHO). Asthma fact sheet no. 207. 2011 World Health Organization (WHO). Asthma fact sheet no. 207. 2011
2.
go back to reference Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics. 1992;90:657–62.PubMed Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics. 1992;90:657–62.PubMed
3.
go back to reference Tough SC, Hessel PA, Ruff M, Green FH, Mitchell I, Butt JC. Features that distinguish those who die from asthma from community controls with asthma. J Asthma. 1998;35:657–65.PubMedCrossRef Tough SC, Hessel PA, Ruff M, Green FH, Mitchell I, Butt JC. Features that distinguish those who die from asthma from community controls with asthma. J Asthma. 1998;35:657–65.PubMedCrossRef
4.
go back to reference Vollmer WM, Markson LE, O’Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med. 2002;165:195–9.PubMed Vollmer WM, Markson LE, O’Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med. 2002;165:195–9.PubMed
5.
go back to reference Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62:126–33.PubMed Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62:126–33.PubMed
6.
go back to reference Szefler SJ, Zeiger RS, Haselkorn T, et al. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2011;107:110–9.PubMedCrossRef Szefler SJ, Zeiger RS, Haselkorn T, et al. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2011;107:110–9.PubMedCrossRef
7.
go back to reference •• Global Initiative for Asthma (GINA). The global strategy for asthma management and prevention. 2011. Available at: http://www.ginasthma.org (accessed 31 July 2012). Major global guidelines for the management of asthma. •• Global Initiative for Asthma (GINA). The global strategy for asthma management and prevention. 2011. Available at: http://​www.​ginasthma.​org (accessed 31 July 2012). Major global guidelines for the management of asthma.
8.
go back to reference Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32–9.PubMedCrossRef Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32–9.PubMedCrossRef
9.
go back to reference Chipps BE, Szefler SJ, Simons FE, et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2007;119:1156–63.PubMedCrossRef Chipps BE, Szefler SJ, Simons FE, et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2007;119:1156–63.PubMedCrossRef
10.
go back to reference Borish L, Chipps B, Deniz Y, Gujrathi S, Zheng B, Dolan CM. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2005;95:247–53.PubMedCrossRef Borish L, Chipps B, Deniz Y, Gujrathi S, Zheng B, Dolan CM. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2005;95:247–53.PubMedCrossRef
11.
go back to reference Haselkorn T, Szefler SJ, Simons FE, Zeiger, et al. Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR. Pediatr Allergy Immunol. 2010;21:1157–65.PubMedCrossRef Haselkorn T, Szefler SJ, Simons FE, Zeiger, et al. Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR. Pediatr Allergy Immunol. 2010;21:1157–65.PubMedCrossRef
14.
go back to reference Pollart SM, Elward KS. Overview of changes to asthma guidelines: diagnosis and screening. Am Fam Physician. 2009;79:761–7.PubMed Pollart SM, Elward KS. Overview of changes to asthma guidelines: diagnosis and screening. Am Fam Physician. 2009;79:761–7.PubMed
15.
go back to reference • Chipps BE, Zeiger RS, Borish L, et al. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2012. [Epub ahead of print]. A review article focusing on the most important lessons learnt from the TENOR study relating to burden of illness, quality of life, asthma control and exacerbation, IgE and allergen sensitization, special populations within TENOR, clinical tools, and genetic studies. • Chipps BE, Zeiger RS, Borish L, et al. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2012. [Epub ahead of print]. A review article focusing on the most important lessons learnt from the TENOR study relating to burden of illness, quality of life, asthma control and exacerbation, IgE and allergen sensitization, special populations within TENOR, clinical tools, and genetic studies.
16.
go back to reference Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481–9.PubMedCrossRef Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481–9.PubMedCrossRef
17.
go back to reference • Haselkorn T, Zeiger RS, Chipps BE, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124:921–7. This study showed that recent severe asthma exacerbation is an important predictor of future exacerbation in children.PubMedCrossRef • Haselkorn T, Zeiger RS, Chipps BE, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124:921–7. This study showed that recent severe asthma exacerbation is an important predictor of future exacerbation in children.PubMedCrossRef
18.
go back to reference Sullivan SD, Wenzel SE, Bresnahan BW, et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy. 2007;62:655–60.PubMedCrossRef Sullivan SD, Wenzel SE, Bresnahan BW, et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy. 2007;62:655–60.PubMedCrossRef
19.
go back to reference • Haselkorn T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2009;124:895–902. This study found that future exacerbation in individual patients can be predicted by use of asthma control defined by the impairment domain of the NHLBI 2007 asthma guidelines.PubMedCrossRef • Haselkorn T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2009;124:895–902. This study found that future exacerbation in individual patients can be predicted by use of asthma control defined by the impairment domain of the NHLBI 2007 asthma guidelines.PubMedCrossRef
20.
go back to reference • Zeiger RS, Yegin A, Simons FE, et al. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Ann Allergy Asthma Immunol. 2012;108:81–7. This study was the first to evaluate whether individual components of the impairment domain of the 2007 NHLBI asthma guidelines could independently predict future asthma exacerbation and whether some components may be more important than others.PubMedCrossRef • Zeiger RS, Yegin A, Simons FE, et al. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Ann Allergy Asthma Immunol. 2012;108:81–7. This study was the first to evaluate whether individual components of the impairment domain of the 2007 NHLBI asthma guidelines could independently predict future asthma exacerbation and whether some components may be more important than others.PubMedCrossRef
21.
go back to reference Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol. 2006;96:406–14.PubMedCrossRef Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol. 2006;96:406–14.PubMedCrossRef
22.
go back to reference Burgess JA, Walters EH, Byrnes GB, et al. Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study. Eur Respir J. 2007;29:668–75.PubMedCrossRef Burgess JA, Walters EH, Byrnes GB, et al. Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study. Eur Respir J. 2007;29:668–75.PubMedCrossRef
23.
24.
go back to reference Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedon JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127:741–9.PubMedCrossRef Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedon JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127:741–9.PubMedCrossRef
25.
go back to reference Haselkorn T, Fish JE, Chipps BE, Miller DP, Chen H, Weiss ST. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. Respir Med. 2009;103:274–83.PubMedCrossRef Haselkorn T, Fish JE, Chipps BE, Miller DP, Chen H, Weiss ST. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. Respir Med. 2009;103:274–83.PubMedCrossRef
26.
go back to reference El-Ekiaby A, Brianas L, Skowronski ME, et al. Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness. Am J Respir Crit Care Med. 2006;174:508–13.PubMedCrossRef El-Ekiaby A, Brianas L, Skowronski ME, et al. Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness. Am J Respir Crit Care Med. 2006;174:508–13.PubMedCrossRef
27.
go back to reference Wechsler ME, Castro M, Lehman E, et al. Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med. 2011;184:1247–53.PubMedCrossRef Wechsler ME, Castro M, Lehman E, et al. Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med. 2011;184:1247–53.PubMedCrossRef
28.
go back to reference Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD. Effect of race on asthma management and outcomes in a large, integrated managed care organization. Arch Intern Med. 2007;167:1846–52.PubMedCrossRef Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD. Effect of race on asthma management and outcomes in a large, integrated managed care organization. Arch Intern Med. 2007;167:1846–52.PubMedCrossRef
29.
go back to reference Haselkorn T, Lee JH, Mink DR, Weiss ST. Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2008;101:256–63.PubMedCrossRef Haselkorn T, Lee JH, Mink DR, Weiss ST. Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2008;101:256–63.PubMedCrossRef
30.
go back to reference Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405–13.PubMedCrossRef Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405–13.PubMedCrossRef
31.
go back to reference Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–23.PubMedCrossRef Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–23.PubMedCrossRef
32.
go back to reference Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med. 2008;102:1473–82.PubMedCrossRef Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med. 2008;102:1473–82.PubMedCrossRef
33.
go back to reference Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007;132:1882–9.PubMedCrossRef Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007;132:1882–9.PubMedCrossRef
34.
go back to reference Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med. 2006;100:273–8.PubMedCrossRef Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med. 2006;100:273–8.PubMedCrossRef
35.
go back to reference Mascia K, Borish L, Patrie J, Hunt J, Phillips CD, Steinke JW. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2005;94:652–7.PubMedCrossRef Mascia K, Borish L, Patrie J, Hunt J, Phillips CD, Steinke JW. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2005;94:652–7.PubMedCrossRef
36.
go back to reference Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116:970–5.PubMedCrossRef Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116:970–5.PubMedCrossRef
37.
go back to reference American Thoracic Society (ATS). Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162:2341–51. American Thoracic Society (ATS). Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162:2341–51.
Metadata
Title
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort
Authors
Bradley E. Chipps
Robert S. Zeiger
Alejandro Dorenbaum
Larry Borish
Sally E. Wenzel
Dave P. Miller
Mary Lou Hayden
Eugene R. Bleecker
F. Estelle R. Simons
Stanley J. Szefler
Scott T. Weiss
Tmirah Haselkorn
TENOR Study Group
Publication date
01-12-2012
Publisher
Current Science Inc.
Published in
Current Pulmonology Reports / Issue 4/2012
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-012-0025-x

Other articles of this Issue 4/2012

Current Pulmonology Reports 4/2012 Go to the issue

Interstitial Lung Disease (G Tino, Section Editor)

Connective tissue disease-associated interstitial lung disease: a review

Interstitial Lung Disease (G Tino, Section Editor)

Non-pharmacological treatment of idiopathic pulmonary fibrosis

Interstitial Lung Disease (G Tino, Section Editor)

Diagnostic approach to interstitial lung disease

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.